SUBSTITUTED CYCLOALKANOL ETHERS OF PSYCHOSTIMULANT ACTIVITY - STUDIES ON QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS

被引：0

作者：

DARVAS, F

BUDAI, Z

PETOCZ, L

KOSOCZKY, I

机构：

[1] NIM IGUSZI,POB 33,1363 BUDAPEST,HUNGARY

[2] EGYT PHARMACOCHEM WORKS,POB 100,1475 BUDAPEST,HUNGARY

来源：

RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 1975年 / 12卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：243 / 254

页数：12

共 11 条

[1] ARIENS EJ, 1971, DRUG DESIGN, V1
[2] FLUDILAT R, 1971, ROTE LISTE CANTOR, P502
[3] HANSCH C, 1965, MOL PHARMACOL, V1, P205
[4] RHO-SIGMA-PI ANALYSIS . METHOD FOR CORRELATION OF BIOLOGICAL ACTIVITY + CHEMICAL STRUCTURE
HANSCH, C
FUJITA, T
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) : 1616 - &
[5] STRUCTURE-ACTIVITY RELATIONSHIP IN BARBITURATES AND ITS SIMILARITY TO THAT IN OTHER NARCOTICS
HANSCH, C
ANDERSON, SM
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (05) : 745 - &
[6] KOMLOS E, 1970, ARZNEI-FORSCHUNG, V20, P1338
[7] KOSOCZKY I, 1966, ACTA PHYSIOL HUNG, V30, P309
[8] STRUCTURAL REQUIREMENTS FOR CENTRALLY ACTING DRUGS I
LIEN, EJ
TONG, GL
CHOU, JT
LIEN, LL
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (02) : 246 - 250
[9] PALLOS L, 1972, ARZNEI-FORSCHUNG, V22, P1502
[10] PURCELL WP, 1973, STRATEGY DRUG DESIGN